Verrica Pharmaceuticals Inc. Credit Agreements
5 Contracts & Agreements
- Fifth Amendment to Credit Agreement, dated as of August 2, 2024, by and between the Registrant and OrbiMed Royalty & Credit Opportunities IV, LP (Filed With SEC on August 14, 2024)
- Fourth Amendment to Credit Agreement, dated as of June 26, 2024, by and between the Registrant and OrbiMed Royalty & Credit Opportunities IV, LP (Filed With SEC on August 14, 2024)
- Third Amendment to Credit Agreement, dated as of May 6, 2024, by and between the Registrant and OrbiMed Royalty & Credit Opportunities IV, LP (Filed With SEC on August 14, 2024)
- Second Amendment to Credit Agreement, dated as of January 31, 2024, by and between the Registrant and Orbimed Royalty & Credit Opportunities IV, LP (Filed With SEC on February 29, 2024)
- First Amendment to Credit Agreement, dated as of December 20, 2023, by and between the Registrant and Orbimed Royalty & Credit Opportunities IV, LP (Filed With SEC on February 29, 2024)
